Best Immunology Journals (2026): Ranked by Impact and Accessibility

1. Nature Immunology (IF ~27)

Nature Immunology is the top-ranked specialty journal in the field. It publishes both fundamental and translational immunology, with a preference for papers that reveal new principles of immune function. The journal wants mechanistic depth paired with physiological relevance. In vitro studies without in vivo validation rarely make it, and clinical observations without mechanistic explanation get redirected to clinical journals.

Acceptance rate: ~7-8%. APC: None (hybrid OA). Review time: 6-10 weeks. Scope: Innate immunity, adaptive immunity, immune regulation, immunotherapy, mucosal immunology.

2. Immunity (IF ~25)

Immunity (Cell Press) is Nature Immunology's primary competitor. The journal emphasizes molecular and cellular mechanisms of immunity, with particular strength in T cell biology, antigen presentation, and immune signaling. Immunity tends to publish longer, more complete stories than Nature Immunology, so if your paper has multiple mechanistic layers, it fits the format well.

Acceptance rate: ~7-8%. APC: None (hybrid OA). Review time: 6-10 weeks. Scope: Molecular immunology, T cell biology, innate immunity, host-pathogen interactions.

3. Nature Reviews Immunology (IF ~60.9)

Nature Reviews Immunology publishes invited reviews and perspectives, not original research. The IF is extraordinarily high because review articles in immunology get heavily cited. This isn't a submission target for primary research, but understanding its scope helps you identify which topics the field considers important.

Scope: Review articles across all immunology.

These journals publish excellent immunology that advances the field without necessarily rewriting textbooks. New findings in established areas, improved models, and translational insights land here.

4. Journal of Experimental Medicine (IF ~10.6)

JEM is one of the oldest and most respected journals in experimental biology. In immunology, it publishes mechanistic studies with strong in vivo data. JEM values technical rigor, clean genetic models, and physiological relevance. The journal's reviewers are known for demanding thorough revision, and the published product tends to be very polished as a result.

Acceptance rate: ~10%. APC: None (OA option). Review time: 6-10 weeks. Scope: Experimental immunology, infection, inflammation, autoimmunity, cancer immunology.

5. Journal of Allergy and Clinical Immunology (IF ~11)

JACI is the flagship journal for clinical immunology, allergy, and asthma. If your research involves patients, clinical samples, or translational work connecting immune mechanisms to allergic or autoimmune disease, JACI is the top venue. The journal also publishes mechanistic studies with clear clinical relevance.

Acceptance rate: ~12-15%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: Allergy, asthma, clinical immunology, autoimmune diseases, immune deficiencies.

6. Journal of Clinical Investigation (IF ~10.6)

JCI isn't an immunology-only journal, but it publishes a huge volume of immunology research. The journal values translational work that bridges basic science and clinical medicine. If your paper reveals a new mechanism of immune disease with potential therapeutic implications, JCI is a strong target.

Acceptance rate: ~8-10%. APC: None (OA option). Review time: 6-10 weeks. Scope: Translational immunology, immune disease mechanisms, immunotherapy.

7. Science Immunology (IF ~17)

Science Immunology launched in 2016 and quickly established itself in the top tier. The journal publishes both basic and translational immunology, with particular interest in systems immunology, immune aging, and immune responses to emerging infections. Science Immunology is more receptive to computational and single-cell approaches than some older journals.

Acceptance rate: ~8%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: Systems immunology, immune regulation, host defense, immune aging, immunotherapy.

8. Nature Communications (Immunology section) (IF ~15.7)

Nature Communications publishes across all sciences, but its immunology section is substantial. The journal accepts immunology papers that are technically strong and broadly interesting but may not have the field-changing impact required by Nature Immunology. Think of it as the Nature family's strong mid-tier option.

Acceptance rate: ~12-15%. APC: $5,790 (full OA). Review time: 6-10 weeks. Scope: All immunology, broad appeal, open access.

These journals publish solid immunology without requiring field-defining results. Focused mechanistic studies, replication studies, methodological papers, and work in established models find homes here.

9. Journal of Immunology (IF ~4)

The Journal of Immunology (JI) is the flagship journal of the American Association of Immunologists (AAI). It's the most-published-in immunology journal by volume, with a long history dating to 1916. JI accepts a wide range of immunology research, from innate immunity to adaptive responses to immunodeficiency.

JI has a lower IF than the top-tier journals, but it remains widely read and cited within the field. A JI paper reaches the immunology community effectively, and AAI membership values the journal.

Acceptance rate: ~25-30%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: All immunology, both basic and translational.

10. European Journal of Immunology (IF ~5)

EJI is the journal of the European Federation of Immunological Societies. It publishes basic and clinical immunology with a European perspective. The journal is receptive to focused mechanistic studies that might be too narrow for Nature Immunology or Immunity but are technically sound.

Acceptance rate: ~25%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: Basic immunology, clinical immunology, European perspective.

11. Frontiers in Immunology (IF ~5)

Frontiers in Immunology is the largest open-access immunology journal by volume. It publishes across all immunology subfields and has a relatively high acceptance rate. The journal is sometimes criticized for inconsistent peer review quality, but it provides open-access visibility and fast turnaround.

Acceptance rate: ~35-40%. APC: $2,950. Review time: 3-6 weeks. Scope: All immunology, open access, rapid publication.

12. Mucosal Immunology (IF ~7)

Mucosal Immunology (Nature Publishing Group) is the top specialty journal for gut, lung, and mucosal immune research. If your paper focuses on mucosal immunity, the microbiome-immune axis, or barrier tissue immunology, this is the most focused and well-matched venue.

Acceptance rate: ~15-20%. APC: None (hybrid OA). Review time: 6-10 weeks. Scope: Mucosal immunity, gut immunology, microbiome, barrier tissues, mucosal vaccines.

If your paper reveals a new immune cell type, pathway, or regulatory mechanism, start with Nature Immunology or Immunity. These are the journals for field-defining mechanistic discoveries.

If your paper is translational, connecting immune mechanisms to clinical disease, JCI or Science Immunology are strong fits. JACI is the best choice for allergy and autoimmune disease specifically.

If your paper is a focused mechanistic study in an established area, JEM or Journal of Immunology are good targets depending on the depth and novelty. JEM wants the full story with in vivo validation. JI accepts more focused contributions.

If your paper involves clinical samples or patient data, JACI for allergy/autoimmunity, or clinical journals in the relevant disease area (e.g., Annals of the Rheumatic Diseases for autoimmune arthritis, Blood for immune hematology).

If your paper is primarily computational or single-cell analysis, Science Immunology and Nature Communications are more receptive to data-heavy computational approaches than traditional immunology journals.

If your paper needs open-access visibility, Frontiers in Immunology provides the fastest path. Nature Communications is a higher-impact OA option but more selective and expensive.